Annual report
4538.TEDINET S100R6DG
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥51.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥49.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥49.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥46.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥46.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.2bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥1.9bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.2bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.2bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.2bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.9bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥707m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥894m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥72.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥69.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥69.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥69.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥71.7bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥36.8bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥34.8bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥35.6bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥34.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥33.7bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥32.3bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥32.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥8.0bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.1bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.8bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.9bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.2bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥978m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥813m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥313m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥183.07 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥169.09 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.18 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.59 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.96 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥70 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥4,064.76 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,936.7 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,839.54 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,681.46 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,742.48 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 49.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.2% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.8% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.2% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,451,169 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,314 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 1,344 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 1,356 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 1,352 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 1,347 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2023-03-31 | 1259 pure |
| Real Estate Businessreportable segment | employees | at 2023-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,075
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 3498000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 2853000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -2369000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -1485000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -978000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1553000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -1373000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -313000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -1799000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -2446000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1671000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -813000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 4826000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 7268000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 7074000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 7347000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 8014000000 | JPY |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 1347 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 1352 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 1356 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 1344 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1314 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.923 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.950 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.790 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.859 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.971 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.221 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.865 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.246 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.823 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.318 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1314 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 41.5 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 19.6 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5527000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00953-000PharmaceuticalBusinessReportableSegmentMember | 1259 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00953-000RealEstateBusinessReportableSegmentMember | 1 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 54 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1314 | |
| Research and development expenses research and development activities | CurrentYearDuration | 1353000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 2280000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 9451169 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 9451169 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 9451169 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 9451169 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 25 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 24 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |